NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, San Diego, CA, USA.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28.
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to the rising prevalence of obesity and increased alcohol consumption on the one hand, and improvements in the management of hepatitis B virus and hepatitis C virus infections on the other, the epidemiology and burden of cirrhosis are changing. In this Review, we highlight global trends in the epidemiology of cirrhosis, discuss the contributions of various aetiologies of liver disease, examine projections for the burden of cirrhosis, and suggest future directions to tackle this condition. Although viral hepatitis remains the leading cause of cirrhosis worldwide, the prevalence of non-alcoholic fatty liver disease (NAFLD) and alcohol-associated cirrhosis are rising in several regions of the world. The global number of deaths from cirrhosis increased between 2012 and 2017, but age-standardized death rates (ASDRs) declined. However, the ASDR for NAFLD-associated cirrhosis increased over this period, whereas ASDRs for other aetiologies of cirrhosis declined. The number of deaths from cirrhosis is projected to increase in the next decade. For these reasons, greater efforts are required to facilitate primary prevention, early detection and treatment of liver disease, and to improve access to care.
肝硬化是全球慢性肝病患者发病率和死亡率的重要原因。2019 年,肝硬化导致全球 2.4%的人死亡。由于肥胖症患病率的上升和酒精摄入量的增加,以及乙型肝炎病毒和丙型肝炎病毒感染管理的改善,肝硬化的流行病学和负担正在发生变化。在这篇综述中,我们强调了肝硬化流行病学的全球趋势,讨论了各种肝病病因的贡献,检查了肝硬化负担的预测,并提出了应对这一疾病的未来方向。尽管病毒性肝炎仍然是全球肝硬化的主要原因,但在世界上一些地区,非酒精性脂肪性肝病(NAFLD)和酒精性肝硬化的患病率正在上升。2012 年至 2017 年期间,全球肝硬化死亡人数有所增加,但年龄标准化死亡率(ASDR)有所下降。然而,在此期间,NAFLD 相关性肝硬化的 ASDR 有所上升,而其他病因的肝硬化的 ASDR 则有所下降。预计未来十年肝硬化死亡人数将会增加。因此,需要做出更大的努力来促进肝病的一级预防、早期发现和治疗,并改善获得护理的机会。